Crombez Eric 4

What Happened
Eric Crombez, a director of ABEONA THERAPEUTICS INC. (ABEO), received a grant/award of 37,313 restricted common shares on January 26, 2026. The award was recorded at $0.00 per share (total reported value $0) as an issuance of restricted stock rather than a purchase or sale.

Key Details

• Transaction date: 2026-01-26 (reported on Form 4 filed 2026-01-27). Filing appears timely (within the SEC’s 2-business-day rule).
• Transaction type/code: A (Award/Grant/Other Acquisition) — 37,313 shares @ $0.00; total reported cash value $0.
• Vesting: Per footnote F1, all restricted stock will vest on January 26, 2027.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• No 10b5-1 plan, tax withholding, or sale/exercise was indicated in this transaction.

Context
Restricted stock grants are typically compensation and carry vesting conditions (here, a one-year vesting). They are not an open-market purchase or sale and do not indicate an immediate liquidity event. For retail investors, such awards show management or directors being compensated with company stock, which aligns their interests with shareholders over the vesting period but is standard corporate practice rather than a direct trading signal.